Independent modes of natural killing distinguished in mice lacking Lag3

Science

Volumn 272, Issue 5260, 1996, Pages 405-408

  Miyazaki, Toru ^a   Dierich, Andrée ^a   Benoist, Christophe ^a   Mathis, Diane ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; FEMALE; GENE LOSS; GENE MUTATION; HISTOCOMPATIBILITY COMPLEX; IMMUNOGENETICS; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030009494     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.272.5260.405     Document Type: Article

References (49)

1. F. Triebel et al., J Exp. Med. 171, 1393 (1990).
2. T. Miyazaki et al., in preparation.
3. E. Baixeras et al., J. Exp Med. 176, 327 (1992); B. Huard, P. Prigent, M. Tournier, D. Bruniquel, F Triebel, Eur. J. Immunol. 25, 2718 (1995).
4. E. Baixeras et al., J. Exp Med. 176, 327 (1992); B. Huard, P. Prigent, M. Tournier, D. Bruniquel, F Triebel, Eur. J. Immunol. 25, 2718 (1995).
5. R. M Locksley, S. L. Reiner, F. Hatam, D. R. Littman, N Killeen, Science 261, 1448 (1993).
6. T. Miyazaki, A. Dierich, C. Benoist, D. Mathis, Int. Immunol., in press.
7. W. M. Yokoyama, Annu. Rev. Immunol. 11, 613 (1993), S. F Ziegler et al., J. Immunol 152, 1228 (1994); W. M. Yokoyama et al., ibid. 147, 3229 (1991), R Giorda and M Trucco, ibid., p. 1701, W. M. Yokoyama, P. J. Kehn, D I Cohen, E. M Shevach, ibid. 145, 2353 (1990); E. R Stoneman et al., J. Exp. Med. 182, 305 (1995).
8. W. M. Yokoyama, Annu. Rev. Immunol. 11, 613 (1993), S. F Ziegler et al., J. Immunol 152, 1228 (1994); W. M. Yokoyama et al., ibid. 147, 3229 (1991), R Giorda and M Trucco, ibid., p. 1701, W. M. Yokoyama, P. J. Kehn, D I Cohen, E. M Shevach, ibid. 145, 2353 (1990); E. R Stoneman et al., J. Exp. Med. 182, 305 (1995).
9. W. M. Yokoyama, Annu. Rev. Immunol. 11, 613 (1993), S. F Ziegler et al., J. Immunol 152, 1228 (1994); W. M. Yokoyama et al., ibid. 147, 3229 (1991), R Giorda and M Trucco, ibid., p. 1701, W. M. Yokoyama, P. J. Kehn, D I Cohen, E. M Shevach, ibid. 145, 2353 (1990); E. R Stoneman et al., J. Exp. Med. 182, 305 (1995).
10. W. M. Yokoyama, Annu. Rev. Immunol. 11, 613 (1993), S. F Ziegler et al., J. Immunol 152, 1228 (1994); W. M. Yokoyama et al., ibid. 147, 3229 (1991), R Giorda and M Trucco, ibid., p. 1701, W. M. Yokoyama, P. J. Kehn, D I Cohen, E. M Shevach, ibid. 145, 2353 (1990); E. R Stoneman et al., J. Exp. Med. 182, 305 (1995).
11. W. M. Yokoyama, Annu. Rev. Immunol. 11, 613 (1993), S. F Ziegler et al., J. Immunol 152, 1228 (1994); W. M. Yokoyama et al., ibid. 147, 3229 (1991), R Giorda and M Trucco, ibid., p. 1701, W. M. Yokoyama, P. J. Kehn, D I Cohen, E. M Shevach, ibid. 145, 2353 (1990); E. R Stoneman et al., J. Exp. Med. 182, 305 (1995).
12. W. M. Yokoyama, Annu. Rev. Immunol. 11, 613 (1993), S. F Ziegler et al., J. Immunol 152, 1228 (1994); W. M. Yokoyama et al., ibid. 147, 3229 (1991), R Giorda and M Trucco, ibid., p. 1701, W. M. Yokoyama, P. J. Kehn, D I Cohen, E. M Shevach, ibid. 145, 2353 (1990); E. R Stoneman et al., J. Exp. Med. 182, 305 (1995).
13. C. L. Sentman, V. Kumar, G. Koo, M. Bennett, J. Immunol. 142, 1847 (1989).
14. N. Killeen, S. Sawada, D R. Littman, EMBO J 12, 1547 (1993).
15. F. M. Karlhofer, R. K. Ribaudo, W. M. Yokoyama, Nature 358, 66 (1992).
16. K. Kärre, Semin Immunol. Ser 5, 127 (1993); G. Trinchieri, J. Exp. Med. 180, 417 (1994); W M. Yokoyama, Proc Natl. Acad. Sci U.S.A 92, 3081 (1995).
17. K. Kärre, Semin Immunol. Ser 5, 127 (1993); G. Trinchieri, J. Exp. Med. 180, 417 (1994); W M. Yokoyama, Proc Natl. Acad. Sci U.S.A 92, 3081 (1995).
18. K. Kärre, Semin Immunol. Ser 5, 127 (1993); G. Trinchieri, J. Exp. Med. 180, 417 (1994); W M. Yokoyama, Proc Natl. Acad. Sci U.S.A 92, 3081 (1995).
19. N.-S. Liao, M. Bix, M. Zijlstra, R. Jaenisch, D Raulet, Science 253, 199 (1991), P. Höglund et al., Proc. Natl Acad. Sci. U.S.A. 88, 10332 (1991).
20. N.-S. Liao, M. Bix, M. Zijlstra, R. Jaenisch, D Raulet, Science 253, 199 (1991), P. Höglund et al., Proc. Natl Acad. Sci. U.S.A. 88, 10332 (1991).
21. Y. Y. L. Yu, V. Kumar, M Bennett, Annu. Rev. Immunol 10, 189 (1992).
22. T. Miyazaki, unpublished data.
23. -/- mice with a LAG3-derived 26-residue peptide (Ser-Gly-Gln-Pro-Thr-Pro-Ile-Pro-Ala-Leu-Asp-Leu-His-Gln-Gly-Met-Pro-Ser-Pro- Arg-Gln-Pro-Ala-Pro-Gly-Arg) conjugated to ovalbumin. The antiserum was adsorbed before use with total spleen cells from LAC3-deficient mice, and its specificity was ascertained by its ability to stain Con A blasts from normal, but not from LAG3-deficient, mice
24. W M Yokoyama, Curr. Opin. Immunol. 7, 110 (1995); D. Raulet and W. Held, Cell 82, 697 (1995).
25. W M Yokoyama, Curr. Opin. Immunol. 7, 110 (1995); D. Raulet and W. Held, Cell 82, 697 (1995).
26. K. Bezouska et al., Nature 372, 150 (1994); J. C. Ryan, E. C. Niemi, M C Nakamura, W. E. Seaman, J Exp. Med. 181, 1911 (1995).
27. K. Bezouska et al., Nature 372, 150 (1994); J. C. Ryan, E. C. Niemi, M C Nakamura, W. E. Seaman, J Exp. Med. 181, 1911 (1995).
28. K. Karre, in Mechanisms of Cytotoxicity by NK Cells, R. B. Herberman and D. M. Callewaert, Eds. (Academic Press, Orlando, FL, 1985), pp. 81-96, H. G. Ljungg ren and K. Kärre, Immunol. Today 11, 7 (1990).
29. K. Karre, in Mechanisms of Cytotoxicity by NK Cells, R. B. Herberman and D. M. Callewaert, Eds. (Academic Press, Orlando, FL, 1985), pp. 81-96, H. G. Ljungg ren and K. Kärre, Immunol. Today 11, 7 (1990).
30. E. Ciccone et al., J. Exp. Med 175, 709 (1992); E Ciccone et al , ibid 176, 963 (1992 ) ; M. Colonna, E. G. Brooks, M. Falco, G. B. Ferrara, J. L. Strominger, Science 260, 1121 (1993); M. Cella, A. Longo, G. B. Ferrara, J. L. Strominger, M. Colonna, J. Exp. Med. 180, 1235 (1994); A. Moretta et al., ibid., p 545.
31. E. Ciccone et al., J. Exp. Med 175, 709 (1992); E Ciccone et al , ibid 176, 963 (1992 ) ; M. Colonna, E. G. Brooks, M. Falco, G. B. Ferrara, J. L. Strominger, Science 260, 1121 (1993); M. Cella, A. Longo, G. B. Ferrara, J. L. Strominger, M. Colonna, J. Exp. Med. 180, 1235 (1994); A. Moretta et al., ibid., p 545.
32. E. Ciccone et al., J. Exp. Med 175, 709 (1992); E Ciccone et al , ibid 176, 963 (1992 ) ; M. Colonna, E. G. Brooks, M. Falco, G. B. Ferrara, J. L. Strominger, Science 260, 1121 (1993); M. Cella, A. Longo, G. B. Ferrara, J. L. Strominger, M. Colonna, J. Exp. Med. 180, 1235 (1994); A. Moretta et al., ibid., p 545.
33. E. Ciccone et al., J. Exp. Med 175, 709 (1992); E Ciccone et al , ibid 176, 963 (1992 ) ; M. Colonna, E. G. Brooks, M. Falco, G. B. Ferrara, J. L. Strominger, Science 260, 1121 (1993); M. Cella, A. Longo, G. B. Ferrara, J. L. Strominger, M. Colonna, J. Exp. Med. 180, 1235 (1994); A. Moretta et al., ibid., p 545.
34. E. Ciccone et al., J. Exp. Med 175, 709 (1992); E Ciccone et al , ibid 176, 963 (1992 ) ; M. Colonna, E. G. Brooks, M. Falco, G. B. Ferrara, J. L. Strominger, Science 260, 1121 (1993); M. Cella, A. Longo, G. B. Ferrara, J. L. Strominger, M. Colonna, J. Exp. Med. 180, 1235 (1994); A. Moretta et al., ibid., p 545.
35. V Litwin, J. Gumperz, P. Parham, J. H Phillips, L L. Lanier, J Exp Med. 178, 321 (1993).
36. F. M Karlhofer, M. M. Orihuela, W. M. Yokoyama, ibid. 181, 1785 (1995)
37. G. E Piontek et al., J. Immunol. 135, 4281 (1985); G Dennert, C. Landon, E. M. Lord, D. W. Bahler, J. G. Frelinger, ibid. 140, 2472 (1988) .
38. G. E Piontek et al., J. Immunol. 135, 4281 (1985); G Dennert, C. Landon, E. M. Lord, D. W. Bahler, J. G. Frelinger, ibid. 140, 2472 (1988) .
39. H G. Ljunggren, I . Van Kaer, H L Ploegh, S. Tonegawa, Proc Natl Acad. Sci. U.S.A. 91, 6520 (1994).
40. C L Sentman et al., J Immunol. 153, 5482 (1994); A J Zajac, D. Muller, K. Pederson, J. A. Frelinger, D. G. Quinn, Int. Immunol. 7, 1545 (1995).
41. C L Sentman et al., J Immunol. 153, 5482 (1994); A J Zajac, D. Muller, K. Pederson, J. A. Frelinger, D. G. Quinn, Int. Immunol. 7, 1545 (1995).
42. 32P-labeled Lag3 cDNA fragment.
43. B. H. Koller, P Marrack, J W. Kappler, O. Smithies, Science 248, 1227 (1990).
44. 7 cells per milliliter) for use in cytotoxicity assays.
45. 7 cells per milliliter) for use in cytotoxicity assays.
46. 7 cells per milliliter) for use in cytotoxicity assays.
47. W. J. Murphy et al., J. Exp. Med. 166, 1499 (1987).
48. 125I]iodo-2′-deoxyundine. Isotope incorporated by the spleens of the recipients was determined the next day after extensive rinsing of the spleens with phosphate-buffered saline.
49. We thank E. Long and D Raulet for helpful comments on the manuscript, D Littman for the CD4 mutant mice; M. Digelmann, J -M. Kuhry, P. André, and M. Duval for help in creating the knockout mice, C. Schricke and F. Fischer for help with care of the mice; P. Gerber and C. Ebel for assistance; P. Eberling and F. Ruffenach for peptides and oligonucleotides; and C. Waltzinger for help with flow cytometry. Supported by funds from INSERM, CNRS, and the Centre Hospitalier Universitaire Régional, and by grants to D.M. and C B from the Association pour la Recherche sur le Cancer and the Human Frontier Science Program. T.M. was supported by a fellowship from the Human Frontier Science Program Organization.